|
NL7013068A
(ru)
|
1969-09-17 |
1971-03-19 |
|
|
|
US4537889A
(en)
|
1982-12-27 |
1985-08-27 |
Eli Lilly And Company |
Inotropic agents
|
|
US4614810A
(en)
|
1984-09-24 |
1986-09-30 |
Pennwalt Corporation |
4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
|
|
US4625040A
(en)
|
1984-09-24 |
1986-11-25 |
Pennwalt Corporation |
N-(phenyl) or N-(phenylcyclopropyl)-2,5-dihydro-2-oxo-4[(substituted phenyl)amino]-3-furancarboxamide derivatives
|
|
FR2607813B1
(fr)
|
1986-12-05 |
1989-03-31 |
Montpellier I Universite |
Alkylamino-8 imidazo (1,2-a) pyrazines et derives, leur preparation et leur application en therapeutique
|
|
JPH032778Y2
(ru)
|
1986-12-15 |
1991-01-24 |
|
|
|
AU622330B2
(en)
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
|
JP2844351B2
(ja)
|
1989-07-13 |
1999-01-06 |
株式会社科薬 |
安定なポリミキシン系抗生物質水性溶液
|
|
IL96432A0
(en)
|
1989-11-30 |
1991-08-16 |
Schering Ag |
Pesticidal compositions containing pyridine derivatives and novel pyridine derivatives
|
|
FR2662163A1
(fr)
|
1990-05-16 |
1991-11-22 |
Lipha |
Nouvelles 8-amino-1,2,4-triazolo(4,3-a) pyrazines, procedes de preparation et medicaments les contenant.
|
|
WO1993025553A1
(en)
|
1992-06-17 |
1993-12-23 |
The Upjohn Company |
Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
|
|
JP2923139B2
(ja)
|
1992-10-05 |
1999-07-26 |
三井化学株式会社 |
製 剤
|
|
DE4327027A1
(de)
|
1993-02-15 |
1994-08-18 |
Bayer Ag |
Imidazoazine
|
|
FR2711993B1
(fr)
|
1993-11-05 |
1995-12-01 |
Rhone Poulenc Rorer Sa |
Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
|
|
US5932223A
(en)
|
1996-09-26 |
1999-08-03 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
|
TR200001728T2
(tr)
|
1997-11-11 |
2000-09-21 |
Ono Pharmaceutical Co., Ltd. |
Birleşik pirazin türevleri
|
|
JP2000319278A
(ja)
|
1999-05-11 |
2000-11-21 |
Ono Pharmaceut Co Ltd |
縮合ピラジン化合物およびその化合物を有効成分とする薬剤
|
|
JP2000319277A
(ja)
|
1999-05-11 |
2000-11-21 |
Ono Pharmaceut Co Ltd |
縮合ピラジン化合物およびその化合物を有効成分とする薬剤
|
|
JP4032566B2
(ja)
|
1999-06-21 |
2008-01-16 |
東レ株式会社 |
発光素子
|
|
JP4041624B2
(ja)
|
1999-07-21 |
2008-01-30 |
三井化学株式会社 |
有機電界発光素子
|
|
JP2001057292A
(ja)
|
1999-08-20 |
2001-02-27 |
Toray Ind Inc |
発光素子
|
|
NZ518052A
(en)
|
1999-09-28 |
2005-04-29 |
Panacea Biotec Ltd |
Controlled release compositions comprising nimesulide (4-nitro-2-phenoxymethanesulfonanilide) for a once-a-day oral dosage to treat diseases such as arthritis
|
|
SE9903611D0
(sv)
|
1999-10-06 |
1999-10-06 |
Astra Ab |
Novel compounds III
|
|
DE19948434A1
(de)
|
1999-10-08 |
2001-06-07 |
Gruenenthal Gmbh |
Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
|
|
JP4409680B2
(ja)
|
1999-10-18 |
2010-02-03 |
株式会社ヤクルト本社 |
三環性縮合イミダゾール誘導体
|
|
AU2001252609A1
(en)
|
2000-04-27 |
2001-11-12 |
Imperial Cancer Research Technology Ltd. |
Imidazopyridine derivatives
|
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
AU2002215608B2
(en)
|
2000-06-28 |
2004-12-09 |
Smithkline Beecham P.L.C. |
Wet milling process
|
|
AR029538A1
(es)
|
2000-07-06 |
2003-07-02 |
Wyeth Corp |
Composiciones farmaceuticas de agentes estrogenicos
|
|
AU2001276903A1
(en)
|
2000-07-14 |
2002-01-30 |
Bristol-Myers Squibb Pharma Company |
Imidazo(1,2-a)pyrazines for the treatment of neurological disorders
|
|
DE10050663A1
(de)
|
2000-10-13 |
2002-04-18 |
Gruenenthal Gmbh |
Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
|
|
WO2002034748A1
(en)
|
2000-10-24 |
2002-05-02 |
Sankyo Company, Limited |
Imidazopyridine derivatives
|
|
JP2002205992A
(ja)
|
2000-11-08 |
2002-07-23 |
Takeda Chem Ind Ltd |
二環式トリアゾロン誘導体およびそれを含有する除草剤
|
|
US6936608B2
(en)
|
2000-11-10 |
2005-08-30 |
Merck Sharp & Dohme Ltd. |
Imidazo-triazine derivatives as ligands for GABA receptors
|
|
EP1343785A2
(de)
|
2000-12-13 |
2003-09-17 |
Basf Aktiengesellschaft |
Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
|
EP1377549A1
(en)
|
2001-03-12 |
2004-01-07 |
Millennium Pharmaceuticals, Inc. |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
IL159811A0
(en)
|
2001-07-13 |
2004-06-20 |
Neurogen Corp |
Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
|
|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
|
WO2004017950A2
(en)
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
US20060276339A1
(en)
|
2002-10-16 |
2006-12-07 |
Windsor J B |
Methods and compositions for increasing the efficacy of biologically-active ingredients
|
|
WO2004058762A1
(en)
|
2002-12-20 |
2004-07-15 |
Pharmacia Corporation |
Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
|
|
US7189723B2
(en)
|
2003-02-10 |
2007-03-13 |
Cgi Pharmaceuticals, Inc. |
Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
|
|
GB0303910D0
(en)
|
2003-02-20 |
2003-03-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US7157460B2
(en)
|
2003-02-20 |
2007-01-02 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
|
US7186832B2
(en)
|
2003-02-20 |
2007-03-06 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
|
BRPI0408332A
(pt)
|
2003-03-14 |
2006-03-21 |
Ono Pharmaceutical Co |
derivados heterocìclicos contendo nitrogênio e medicamentos contendo os mesmos como ingrediente ativo
|
|
DK1615647T3
(da)
|
2003-04-11 |
2010-04-06 |
High Point Pharmaceuticals Llc |
Farmaceutisk anvendelse af kondenserede 1,2,4-triazoler
|
|
JP2006522750A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
代謝性症候群ならびに関連の疾患および障害を治療するために、１１β−ヒドロキシステロイドデヒドロゲナーゼ１型阻害剤および抗高血圧剤を使用する併用療法
|
|
ATE512957T1
(de)
|
2003-04-24 |
2011-07-15 |
Merck Sharp & Dohme |
Hemmer der akt aktivität
|
|
SE0301653D0
(sv)
|
2003-06-05 |
2003-06-05 |
Astrazeneca Ab |
Novel compounds
|
|
NZ544200A
(en)
|
2003-07-14 |
2009-07-31 |
Arena Pharm Inc |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
|
JP4870562B2
(ja)
|
2003-09-12 |
2012-02-08 |
メルク セローノ ソシエテ アノニム |
糖尿病の治療のためのスルホンアミド誘導体
|
|
JP2005089352A
(ja)
|
2003-09-16 |
2005-04-07 |
Kissei Pharmaceut Co Ltd |
新規なイミダゾ［１，５−ａ］ピラジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
EP1678180B1
(en)
|
2003-10-10 |
2007-08-08 |
Pfizer Products Incorporated |
Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors
|
|
US7419978B2
(en)
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
|
CA2543707A1
(en)
|
2003-10-31 |
2005-05-19 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing fused heterocyclic compounds
|
|
WO2005063241A1
(ja)
|
2003-12-26 |
2005-07-14 |
Ono Pharmaceutical Co., Ltd. |
ミトコンドリアベンゾジアゼピン受容体介在性疾患の予防および／または治療剤
|
|
US20070191395A1
(en)
|
2004-02-16 |
2007-08-16 |
Katsuhiro Kawakami |
Heterocyclic compounds having antifungal activity
|
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
JP5154924B2
(ja)
|
2004-05-11 |
2013-02-27 |
エガレット エイ／エス |
ジェランガムを含む膨張可能な投与形態
|
|
WO2006131003A1
(en)
|
2005-06-09 |
2006-12-14 |
Oncalis Ag |
Angiogenesis inhibitors
|
|
TW200612918A
(en)
|
2004-07-29 |
2006-05-01 |
Threshold Pharmaceuticals Inc |
Lonidamine analogs
|
|
WO2006018727A2
(en)
|
2004-08-18 |
2006-02-23 |
Pharmacia & Upjohn Company Llc |
Triazolopyridine compounds useful for the treatment of inflammation
|
|
EP1799671A4
(en)
*
|
2004-09-02 |
2009-06-10 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
|
CA2582482A1
(en)
|
2004-10-07 |
2006-04-13 |
Warner-Lambert Company Llc |
Triazolopyridine derivatives as antibacterial agents
|
|
EP1819338A4
(en)
|
2004-11-22 |
2009-11-04 |
Threshold Pharmaceuticals Inc |
ANTICANCER TUBULIN-BINDING AGENTS AND THEIR PRODUCTS
|
|
CA2586796A1
(en)
|
2004-12-01 |
2006-06-08 |
Laboratoires Serono S.A. |
[1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
|
|
US20070293456A9
(en)
|
2004-12-30 |
2007-12-20 |
Anthony Hayford |
Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
|
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
|
ES2366375T3
(es)
|
2005-02-22 |
2011-10-19 |
Pfizer, Inc. |
Derivados de oxiindol, como agonistas del receptor 5-ht4.
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
US7452892B2
(en)
|
2005-06-17 |
2008-11-18 |
Bristol-Myers Squibb Company |
Triazolopyrimidine cannabinoid receptor 1 antagonists
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7572808B2
(en)
|
2005-06-17 |
2009-08-11 |
Bristol-Myers Squibb Company |
Triazolopyridine cannabinoid receptor 1 antagonists
|
|
TW200800213A
(en)
|
2005-09-02 |
2008-01-01 |
Abbott Lab |
Novel imidazo based heterocycles
|
|
EP1931641B1
(en)
*
|
2005-09-09 |
2010-08-25 |
Schering Corporation |
NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
|
|
KR20080074963A
(ko)
|
2005-11-10 |
2008-08-13 |
쉐링 코포레이션 |
단백질 키나제 억제제로서의 이미다조피라진
|
|
MX336930B
(es)
|
2005-11-28 |
2016-02-05 |
Marinus Pharmaceuticals |
Formulaciones de ganaxolona y metodos para la manufactura y el uso de las mismas.
|
|
AU2006331363B2
(en)
|
2005-12-27 |
2012-07-05 |
F. Hoffmann-La Roche Ag |
Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives
|
|
WO2007074491A1
(en)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
|
|
PE20070978A1
(es)
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
RU2008143179A
(ru)
|
2006-03-31 |
2010-05-10 |
Новартис АГ (CH) |
Органические соединения
|
|
US20090175852A1
(en)
|
2006-06-06 |
2009-07-09 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
|
US7557104B2
(en)
|
2006-06-06 |
2009-07-07 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
|
JP2009541323A
(ja)
|
2006-06-22 |
2009-11-26 |
マリンクロット インコーポレイテッド |
拡張された共役を有するピラジン誘導体およびその使用
|
|
EP2029554B1
(en)
|
2006-06-22 |
2014-03-19 |
MediBeacon, LLC |
Pyrazine derivatives and uses thereof in renal monitoring
|
|
US8022088B2
(en)
|
2006-06-29 |
2011-09-20 |
Schering Corporation |
Substituted bicyclic and tricyclic thrombin receptor antagonists
|
|
WO2008005423A1
(en)
|
2006-07-03 |
2008-01-10 |
Cambrex Charles City, Inc. |
Improved method of making sufentanil
|
|
US7501438B2
(en)
|
2006-07-07 |
2009-03-10 |
Forest Laboratories Holdings Limited |
Pyridoimidazole derivatives
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
|
US20080021217A1
(en)
|
2006-07-20 |
2008-01-24 |
Allen Borchardt |
Heterocyclic inhibitors of rho kinase
|
|
US7563797B2
(en)
|
2006-08-28 |
2009-07-21 |
Forest Laboratories Holding Limited |
Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
|
|
DE102006041292A1
(de)
|
2006-09-01 |
2008-03-06 |
Henkel Kgaa |
Wasserstoffperoxid-Aktivierung mit N-Heterocyclen
|
|
WO2008037607A1
(de)
|
2006-09-25 |
2008-04-03 |
Basf Se |
Carbonylgruppen-enthaltende heterocyclische verbindungen und deren verwendung zur bekämpfung von phytopathogenen pilzen
|
|
ATE542818T1
(de)
|
2006-10-11 |
2012-02-15 |
Amgen Inc |
Imidazo- und triazolopyridinverbindungen und verfahren zu deren anwendung
|
|
CN101646419A
(zh)
|
2006-11-08 |
2010-02-10 |
诺瓦瓦克斯股份有限公司 |
制备多相药物组合物的固体剂型的方法
|
|
BRPI0718247B1
(pt)
|
2006-11-08 |
2021-09-21 |
Neurocrine Biosciences, Inc. |
Composto usado como inibidor do transportador de monoamina vesicular 2, composição farmacêutica compreendendo o dito composto e uso da dita composição farmacêutica no tratamento de transtornos hipercinéticos
|
|
WO2008056176A1
(en)
|
2006-11-10 |
2008-05-15 |
Scottish Biomedical Limited |
Pyrazolopyrimidines as phosphodiesterase inhibitors
|
|
DK3034075T3
(en)
|
2006-11-22 |
2018-10-22 |
Incyte Holdings Corp |
IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASEI INHIBITORS
|
|
EP2086540B8
(en)
|
2006-12-01 |
2011-03-02 |
Galapagos N.V. |
Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
|
|
EP2063867A2
(en)
|
2006-12-22 |
2009-06-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
|
EP2118101B1
(en)
|
2007-03-09 |
2012-09-26 |
Probiodrug AG |
Imidazo [1,5-a] pyridine derivatives as inhibitors of glutaminyl cyclase
|
|
DE102007012645A1
(de)
|
2007-03-16 |
2008-09-18 |
Bayer Healthcare Ag |
Substituierte Imidazo- und Triazolopyrimidine
|
|
EP1972628A1
(en)
|
2007-03-21 |
2008-09-24 |
Schwarz Pharma Ag |
Indolizines and aza-analog derivatives thereof as CNS active compounds
|
|
ATE540037T1
(de)
|
2007-04-16 |
2012-01-15 |
Leo Pharma As |
Triazolopyridine als phosphodiesterasehemmer zur behandlung von hautkrankheiten
|
|
CN101687873A
(zh)
|
2007-04-17 |
2010-03-31 |
百时美施贵宝公司 |
具有稠合杂环的11β-羟基类固醇Ⅰ型脱氢酶抑制剂
|
|
US20110206607A1
(en)
|
2007-05-10 |
2011-08-25 |
Roger Olsson |
Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
|
|
CA2687558C
(en)
|
2007-05-21 |
2015-07-14 |
Toray Industries, Inc. |
Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
|
|
JP5451602B2
(ja)
|
2007-06-08 |
2014-03-26 |
アッヴィ・インコーポレイテッド |
キナーゼ阻害薬としての５−ヘテロアリール置換インダゾール類
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
WO2008156614A2
(en)
|
2007-06-14 |
2008-12-24 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
|
CL2008001839A1
(es)
|
2007-06-21 |
2009-01-16 |
Incyte Holdings Corp |
Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
|
|
US20090004281A1
(en)
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
MX2010000716A
(es)
|
2007-07-18 |
2010-03-26 |
Novartis Ag |
Compuestos de heteroarilo biciclicos y su uso como inhibidores de cinasa.
|
|
MX2010001340A
(es)
|
2007-07-31 |
2010-06-02 |
Schering Corp |
Combianacion de agente antimitotico e inhibidor de aurora quinasa como tratamiento anticancerigeno.
|
|
WO2009017954A1
(en)
|
2007-08-01 |
2009-02-05 |
Phenomix Corporation |
Inhibitors of jak2 kinase
|
|
CN101842098A
(zh)
|
2007-08-10 |
2010-09-22 |
基因实验室技术有限公司 |
用于治疗病毒感染的含氮的二环化学实体
|
|
US20090047336A1
(en)
|
2007-08-17 |
2009-02-19 |
Hong Kong Baptist University |
novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
|
|
FR2920091A1
(fr)
|
2007-08-24 |
2009-02-27 |
Oreal |
Composition tinctoriale comprenant une base d'oxydation aminopyrazolopyridine, un coupleur et un polyol particulier.
|
|
FR2920090A1
(fr)
|
2007-08-24 |
2009-02-27 |
Oreal |
Composition tinctoriale comprenant une base d'oxydation aminopyrazolopyridine particuliere, un coupleur et un tensioactif particulier.
|
|
KR20090022616A
(ko)
|
2007-08-31 |
2009-03-04 |
한올제약주식회사 |
베실산클로피도그렐 함유 경구투여용 약제
|
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
EA018512B1
(ru)
|
2007-10-11 |
2013-08-30 |
Астразенека Аб |
Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
|
|
ES2545361T3
(es)
|
2007-10-12 |
2015-09-10 |
Novartis Ag |
Composiciones que comprenden moduladores del receptor de esfingosina 1-fosfato (S1P)
|
|
WO2009085230A1
(en)
|
2007-12-19 |
2009-07-09 |
Amgen Inc. |
Inhibitors of pi3 kinase
|
|
PL2231662T3
(pl)
|
2007-12-19 |
2011-11-30 |
Genentech Inc |
8-anilinoimidazopirydyny oraz ich zastosowanie jako czynników przeciwnowotworowych i/lub przeciwzapalnych
|
|
KR100988233B1
(ko)
|
2007-12-26 |
2010-10-18 |
한미홀딩스 주식회사 |
클로피도그렐 1,5-나프탈렌 다이술폰산 염 또는 이의수화물의 약학 조성물 및 제제
|
|
WO2009114512A1
(en)
|
2008-03-11 |
2009-09-17 |
Incyte Corporation |
Azetidine and cyclobutane derivatives as jak inhibitors
|
|
CN102046175B
(zh)
|
2008-03-12 |
2015-08-12 |
细胞内治疗公司 |
取代的杂环稠合的γ-咔啉固体
|
|
JP5638961B2
(ja)
|
2008-03-13 |
2014-12-10 |
ザ ジェネラル ホスピタル コーポレイション |
Ｂｍｐシグナル伝達経路のインヒビター
|
|
US8637542B2
(en)
*
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
|
EP2277881A4
(en)
|
2008-04-18 |
2011-09-07 |
Shionogi & Co |
HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K
|
|
DE102008023801A1
(de)
|
2008-05-15 |
2009-11-19 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine
|
|
US8349210B2
(en)
|
2008-06-27 |
2013-01-08 |
Transitions Optical, Inc. |
Mesogenic stabilizers
|
|
WO2010010189A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
WO2010010184A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
[1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors
|
|
WO2010010188A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases.
|
|
WO2010010187A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
|
TR200806298A2
(tr)
|
2008-08-22 |
2010-03-22 |
Bi̇lgi̇ç Mahmut |
Farmasötik formülasyon
|
|
JP2010070503A
(ja)
|
2008-09-19 |
2010-04-02 |
Daiichi Sankyo Co Ltd |
抗真菌作用２−アミノトリアゾロピリジン誘導体
|
|
US20120021519A1
(en)
|
2008-09-19 |
2012-01-26 |
Presidents And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
|
JP5731978B2
(ja)
|
2008-09-26 |
2015-06-10 |
インテリカイン， エルエルシー |
複素環キナーゼ阻害剤
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
ES2403633T3
(es)
|
2008-12-04 |
2013-05-20 |
Proximagen Limited |
Compuestos de imidazopiridina
|
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
EP2393813B1
(en)
|
2009-02-04 |
2013-07-31 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11 ß-hydroxysteroid dehydrogenase 1 useful for the treatment of diseases related to elevated level of cortisol
|
|
WO2010090991A1
(en)
|
2009-02-04 |
2010-08-12 |
Supernus Pharmaceuticals, Inc. |
Formulations of desvenlafaxine
|
|
TR200900879A2
(tr)
|
2009-02-05 |
2010-08-23 |
Bi̇lgi̇ç Mahmut |
Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
|
|
TR200900878A2
(tr)
|
2009-02-05 |
2010-08-23 |
Bi̇lgi̇ç Mahmut |
Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
|
|
ES2435804T3
(es)
|
2009-02-13 |
2013-12-23 |
Bayer Intellectual Property Gmbh |
Pirimidinas condensadas como inhibidores de Akt
|
|
WO2010104307A2
(ko)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
|
WO2010107404A1
(en)
|
2009-03-16 |
2010-09-23 |
Mahmut Bilgic |
Stable pharmaceutical combinations
|
|
US8481732B2
(en)
|
2009-03-20 |
2013-07-09 |
Incyte Corporation |
Substituted heterocyclic compounds
|
|
BRPI1013432B1
(pt)
|
2009-03-31 |
2019-12-17 |
Kissei Pharmaceutical |
derivado de indolizina e composição farmacêutica
|
|
BRPI1014572B8
(pt)
|
2009-04-16 |
2022-07-19 |
Fundacion Centro Nac De Investigaciones Oncologicas Carlos Iii |
Imidazopirazinas para uso como inibidores de cinase
|
|
TWI461426B
(zh)
|
2009-05-27 |
2014-11-21 |
Merck Sharp & Dohme |
（二氫）咪唑並異〔５，１－ａ〕喹啉類
|
|
CN102803268A
(zh)
|
2009-06-10 |
2012-11-28 |
桑诺维恩药品公司 |
组胺h3反相激动剂和拮抗剂及其使用方法
|
|
US8686009B2
(en)
|
2009-06-25 |
2014-04-01 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds
|
|
DK2467141T3
(en)
|
2009-08-17 |
2019-02-18 |
Intellikine Llc |
HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
|
|
WO2011022489A2
(en)
|
2009-08-18 |
2011-02-24 |
The Johns Hopkins University |
(bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
WO2011033265A1
(en)
|
2009-09-18 |
2011-03-24 |
Almac Discovery Limited |
Pharmaceutical compounds
|
|
EP2480528B1
(en)
|
2009-09-25 |
2018-08-29 |
Oryzon Genomics, S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
US8614315B2
(en)
|
2009-12-25 |
2013-12-24 |
Mahmut Bilgic |
Cefdinir and cefixime formulations and uses thereof
|
|
EP2526102B1
(en)
|
2010-01-22 |
2017-03-08 |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III |
Inhibitors of PI3 kinase
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
US9616058B2
(en)
|
2010-02-24 |
2017-04-11 |
Oryzon Genomics, S.A. |
Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
|
|
TW201200518A
(en)
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
SG10201502109VA
(en)
|
2010-03-18 |
2015-05-28 |
Pasteur Institut Korea |
Anti-infective compounds
|
|
EP2547680B1
(en)
|
2010-03-18 |
2015-08-05 |
Bayer Intellectual Property GmbH |
Imidazopyrazines
|
|
JP5822911B2
(ja)
|
2010-04-02 |
2015-11-25 |
ユーロスクリーン エス．エー． |
新規のｎｋ−３受容体選択的アンタゴニスト化合物、医薬組成物、及びｎｋ−３受容体媒介疾患における使用方法
|
|
LT2560947T
(lt)
|
2010-04-19 |
2016-12-27 |
Oryzon Genomics, S.A. |
Lizino atžvilgiu specifiniai demetilazės-1 inhibitoriai ir jų panaudojimas
|
|
EP2560949B1
(en)
|
2010-04-20 |
2015-12-02 |
Università degli Studi di Roma "La Sapienza" |
Tranylcypromine derivatives as inhibitors of histone demethylase lsd1 and/or lsd2
|
|
SG183426A1
(en)
*
|
2010-04-28 |
2012-09-27 |
Daiichi Sankyo Co Ltd |
[5,6] heterocyclic compound
|
|
US8957073B2
(en)
|
2010-05-13 |
2015-02-17 |
Amgen Inc. |
Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
|
|
US20130131057A1
(en)
|
2010-05-13 |
2013-05-23 |
Centro Nacional De Investigaciones Oncologicas (Cnio |
New bicyclic compounds as pi3-k and mtor inhibitors
|
|
CN102247321A
(zh)
|
2010-05-20 |
2011-11-23 |
上海亚盛医药科技有限公司 |
一种阿朴棉子酚酮自乳化药物传递系统及其制备方法
|
|
WO2011149438A1
(en)
|
2010-05-28 |
2011-12-01 |
Mahmut Bilgic |
Combination of antihypertensive agents
|
|
CN102295642B
(zh)
|
2010-06-25 |
2016-04-06 |
中国人民解放军军事医学科学院毒物药物研究所 |
2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途
|
|
BR112012033402A2
(pt)
|
2010-07-02 |
2017-01-24 |
Gilead Sciences Inc |
moduladores de canais de íons conforme os compostos heterocíclicos fundidos
|
|
CA2804845A1
(en)
|
2010-07-12 |
2012-01-19 |
Stuart Ince |
Substituted imidazo[1,2-a]pyrimidines and -pyridines
|
|
WO2012009475A1
(en)
|
2010-07-14 |
2012-01-19 |
Oregon Health & Science University |
Methods of treating cancer with inhibition of lysine-specific demethylase 1
|
|
CN101987081B
(zh)
|
2010-07-16 |
2012-08-08 |
钟术光 |
一种控释制剂
|
|
CN101987082B
(zh)
|
2010-07-16 |
2013-04-03 |
钟术光 |
固体制剂及其制备方法
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
PT2598482T
(pt)
|
2010-07-29 |
2018-07-03 |
Oryzon Genomics Sa |
Inibidores de desmetilose de lsd1 com base em arilciclopropilamina e a sua utilização clínica
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
CN102397552B
(zh)
|
2010-09-10 |
2016-06-08 |
广州自远生物科技有限公司 |
一种含喹诺酮类的药物复合制剂及其制备方法和应用
|
|
WO2012034116A2
(en)
|
2010-09-10 |
2012-03-15 |
The Johns Hopkins University |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
CN104592224B
(zh)
|
2010-09-29 |
2016-08-03 |
橘生药品工业株式会社 |
(氮杂)中氮茚衍生物及其药物用途
|
|
US20130303545A1
(en)
|
2010-09-30 |
2013-11-14 |
Tamara Maes |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
JP2013540767A
(ja)
|
2010-10-07 |
2013-11-07 |
ザ ジェイ． デヴィッド グラッドストーン インスティテューツ |
免疫不全ウイルス転写を調節するための組成物および方法
|
|
AU2011318398B2
(en)
|
2010-10-18 |
2015-09-10 |
E. I. Du Pont De Nemours And Company |
Nematocidal sulfonamides
|
|
SG189939A1
(en)
|
2010-10-21 |
2013-06-28 |
Biomarin Pharm Inc |
Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
|
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
|
EP2444084A1
(en)
|
2010-10-21 |
2012-04-25 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Use of PI3K inibitors for the treatment of obesity
|
|
WO2012071469A2
(en)
|
2010-11-23 |
2012-05-31 |
Nevada Cancer Institute |
Histone demethylase inhibitors and uses thereof for treatment o f cancer
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
WO2012080727A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
Casein kinase 1delta (ck1delta) inhibitors
|
|
WO2012080232A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Pharma Aktiengesellschaft |
2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
US20140135319A1
(en)
|
2010-12-17 |
2014-05-15 |
Bayer Intellectual Property Gmbh |
6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
CA2821834A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Intellectual Property Gmbh |
6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
UY33805A
(es)
|
2010-12-17 |
2012-07-31 |
Boehringer Ingelheim Int |
?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.
|
|
CA2821817A1
(en)
|
2010-12-17 |
2012-06-21 |
Bayer Intellectual Property Gmbh |
Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
|
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
|
TWI617559B
(zh)
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
|
|
EP2665726A4
(en)
|
2011-01-21 |
2014-09-03 |
Gen Hospital Corp |
COMPOSITIONS AND METHODS OF TREATING CARDIOVASCULAR DISEASES
|
|
EP3981395A1
(en)
|
2011-02-08 |
2022-04-13 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
EP2712316A1
(en)
|
2011-02-08 |
2014-04-02 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
BRPI1101013A2
(pt)
|
2011-03-03 |
2013-06-04 |
Luciano Rabinowicz |
composiÇço para preparo de bebida energÉtica e bebida energÉtica
|
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
SG193241A1
(en)
|
2011-03-25 |
2013-10-30 |
Glaxosmithkline Ip No 2 Ltd |
Cyclopropylamines as lsd1 inhibitors
|
|
WO2012147890A1
(ja)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
新規アゾール誘導体
|
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
|
WO2012156531A2
(en)
|
2011-05-19 |
2012-11-22 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for inflammatory diseases or conditions
|
|
EP2750671A2
(en)
|
2011-05-19 |
2014-07-09 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for thrombosis and cardiovascular diseases
|
|
AU2012265842A1
(en)
|
2011-06-07 |
2014-01-23 |
SPAI Group Ltd. |
Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof
|
|
MX344479B
(es)
|
2011-06-20 |
2016-12-16 |
Incyte Holdings Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de cinasa janus (jak).
|
|
TW201311149A
(zh)
|
2011-06-24 |
2013-03-16 |
Ishihara Sangyo Kaisha |
有害生物防治劑
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
SG2014009161A
(en)
|
2011-08-09 |
2014-04-28 |
Takeda Pharmaceutical |
Cyclopropaneamine compound
|
|
LT2744330T
(lt)
|
2011-08-15 |
2020-10-26 |
University Of Utah Research Foundation |
Pakeisti (e)-n`-(1-feniletilideno) benzohidrazido analogai, kaip histonų demetilazės inhibitoriai
|
|
US9289415B2
(en)
|
2011-09-01 |
2016-03-22 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancer
|
|
US9273343B2
(en)
|
2011-09-02 |
2016-03-01 |
Promega Corporation |
Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
|
|
CN104703987B
(zh)
|
2011-10-10 |
2017-05-03 |
H.隆德贝克有限公司 |
具有咪唑并吡嗪酮骨架的pde9抑制剂
|
|
CL2014000988A1
(es)
|
2011-10-20 |
2014-11-03 |
Oryzon Genomics Sa |
Compuestos derivados de (aril o heteroaril) ciclopropilamida, inhibidores de lsd1; procedimiento para prepararlos; composicion farmaceutica que los comprende; y metodo para tratar o prevenir cancer, una enfermedad neurologica, una infeccion viral y la reactivacion viral despues de la latencia.
|
|
AU2012324803B9
(en)
|
2011-10-20 |
2017-08-24 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
|
MX351890B
(es)
|
2011-10-20 |
2017-11-01 |
Oryzon Genomics Sa |
Compuestos de (hetero) arilciclopropilamina como inhibidores de lsd1.
|
|
ITMI20111971A1
(it)
|
2011-10-28 |
2013-04-29 |
Mesogenics Srl |
Inibitori dell'enzima lsd-1 per l'induzione del differenziamento osteogenico
|
|
US9266881B2
(en)
|
2011-11-14 |
2016-02-23 |
Merck Sharp & Dohme Corp. |
Triazolopyridinone PDE10 inhibitors
|
|
CA2857964A1
(en)
|
2011-12-05 |
2013-06-13 |
Brandeis University |
Treatment of amyloidosis by compounds that regulate retromer stabilization
|
|
ES2579981T3
(es)
|
2012-03-07 |
2016-08-18 |
Merck Patent Gmbh |
Derivados de triazolopirazina
|
|
CN102579381B
(zh)
|
2012-03-30 |
2013-07-10 |
河南中帅医药科技发展有限公司 |
盐酸胍法辛缓释制剂及其制备方法
|
|
GB201205669D0
(en)
|
2012-03-30 |
2012-05-16 |
Agency Science Tech & Res |
Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof
|
|
CN103373996A
(zh)
|
2012-04-20 |
2013-10-30 |
山东亨利医药科技有限责任公司 |
作为crth2受体拮抗剂的二并环衍生物
|
|
CN105121429B
(zh)
|
2012-06-28 |
2017-12-12 |
诺华股份有限公司 |
补体途径调节剂和其用途
|
|
CN102772444A
(zh)
|
2012-07-06 |
2012-11-14 |
周明千 |
中药超微破壁口服片剂饮片的加工方法
|
|
GB201212513D0
(en)
|
2012-07-13 |
2012-08-29 |
Ucb Pharma Sa |
Therapeutic agents
|
|
AU2013324396B2
(en)
|
2012-09-28 |
2018-10-04 |
Vanderbilt University |
Fused heterocyclic compounds as selective BMP inhibitors
|
|
JP6457942B2
(ja)
|
2012-10-05 |
2019-01-23 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
Ｇｄｆ−８阻害剤
|
|
EP2907802B1
(en)
|
2012-10-12 |
2019-08-07 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
|
EP2919770A4
(en)
|
2012-11-14 |
2017-03-08 |
The Board of Regents of The University of Texas System |
Inhibition of hif-2 heterodimerization with hif1 (arnt)
|
|
JP6238908B2
(ja)
|
2012-11-28 |
2017-11-29 |
京都府公立大学法人 |
リシン構造を有するｌｓｄ１選択的阻害薬
|
|
WO2014085613A1
(en)
|
2012-11-30 |
2014-06-05 |
Mccord Darlene E |
Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
AU2013365945B2
(en)
|
2012-12-19 |
2017-03-02 |
Wockhardt Limited |
A stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
|
CN103054869A
(zh)
|
2013-01-18 |
2013-04-24 |
郑州大学 |
含三唑基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用
|
|
CN103933036B
(zh)
|
2013-01-23 |
2017-10-13 |
中国人民解放军军事医学科学院毒物药物研究所 |
2‑芳基咪唑并[1,2‑α]吡啶‑3‑乙酰胺衍生物在制备防治PTSD的药物中的用途
|
|
EP2956441A4
(en)
|
2013-02-18 |
2016-11-02 |
Scripps Research Inst |
MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
|
|
US8558008B2
(en)
|
2013-02-28 |
2013-10-15 |
Dermira, Inc. |
Crystalline glycopyrrolate tosylate
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
WO2014138791A1
(en)
|
2013-03-13 |
2014-09-18 |
Australian Nuclear Science And Technology Organisation |
Transgenic non-human organisms with non-functional tspo genes
|
|
US20140343118A1
(en)
|
2013-03-14 |
2014-11-20 |
Duke University |
Methods of treatment using arylcyclopropylamine compounds
|
|
JP2016517434A
(ja)
|
2013-03-14 |
2016-06-16 |
エピザイム，インコーポレイティド |
癌を処置するための併用療法
|
|
EP3003301B1
(en)
|
2013-05-30 |
2021-02-24 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Novel suicidal lsd1 inhibitors targeting sox2-expressing cancer cells
|
|
EP3010915B1
(en)
|
2013-06-19 |
2019-05-08 |
University of Utah Research Foundation |
Substituted (3-(5-chloro-2-hydroxyphenyl)-1-benzoyl-1h-pyrazole compounds as histone demethylase inhibitors
|
|
SMT202000071T1
(it)
|
2013-06-21 |
2020-03-13 |
Myokardia Inc |
Composti di pirimidinadione contro le condizioni cardiache
|
|
US9186391B2
(en)
|
2013-08-29 |
2015-11-17 |
Musc Foundation For Research Development |
Cyclic peptide inhibitors of lysine-specific demethylase 1
|
|
US9556170B2
(en)
|
2013-08-30 |
2017-01-31 |
University Of Utah Research Foundation |
Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
DK3043778T3
(da)
|
2013-09-13 |
2017-11-27 |
Bayer Pharma AG |
Farmaceutiske sammensætninger, der indeholder refametinib
|
|
KR101568724B1
(ko)
|
2013-11-13 |
2015-11-12 |
서울대학교산학협력단 |
신규한 화합물, 이의 생산 방법, 및 히스톤 디메틸라제 저해제로서 이의 용도
|
|
ES2935746T3
(es)
|
2013-12-11 |
2023-03-09 |
Celgene Quanticel Res Inc |
Inhibidores de desmetilasa-1 específica de lisina
|
|
PL3110437T3
(pl)
|
2014-02-12 |
2018-04-30 |
Omnigen Research, Llc |
Kompozycja i sposób wspomagania obniżania poziomu stresu cieplnego u zwierząt
|
|
WO2015123424A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
TW201613860A
(en)
|
2014-02-13 |
2016-04-16 |
Incyte Corp |
Cyclopropylamines as LSD1 inhibitors
|
|
US9346776B2
(en)
|
2014-02-13 |
2016-05-24 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
|
US9428470B2
(en)
|
2014-02-13 |
2016-08-30 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
AU2015217073B2
(en)
|
2014-02-13 |
2019-08-22 |
Incyte Holdings Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
WO2015145145A1
(en)
|
2014-03-24 |
2015-10-01 |
Cipla Limited |
Pharmaceutical composition comprising lapatinib
|
|
CN103893163B
(zh)
|
2014-03-28 |
2016-02-03 |
中国药科大学 |
2-([1，1′-联苯]-4-基)2-氧代乙基4-((3-氯-4-甲基苯基)氨基)-4-氧代丁酸酯在制备lsd1抑制剂药物中的应用
|
|
SI3126351T1
(sl)
|
2014-04-02 |
2018-11-30 |
Bristol-Myers Squibb Company |
Biaril kinazni inhibitorji
|
|
WO2015155297A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and h2-receptor antagonists
|
|
US10130618B2
(en)
|
2014-04-11 |
2018-11-20 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
|
CN106459024B
(zh)
|
2014-04-11 |
2019-11-05 |
武田药品工业株式会社 |
环丙胺化合物及其用途
|
|
CN103961340B
(zh)
|
2014-04-30 |
2019-06-25 |
南通中国科学院海洋研究所海洋科学与技术研究发展中心 |
一类lsd1抑制剂及其应用
|
|
WO2015181380A1
(en)
|
2014-05-30 |
2015-12-03 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Cyclopropylamine compounds as histone demethylase inhibitors
|
|
CN104119280B
(zh)
|
2014-06-27 |
2016-03-16 |
郑州大学 |
含氨基类脲与端炔结构单元的嘧啶衍生物、制备方法及应用
|
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
US9695167B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
|
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
GB201417828D0
(en)
|
2014-10-08 |
2014-11-19 |
Cereno Scient Ab |
New methods and compositions
|
|
CN104173313B
(zh)
|
2014-08-25 |
2017-05-17 |
杭州朱养心药业有限公司 |
利伐沙班片剂药物组合物
|
|
JP6653116B2
(ja)
|
2014-08-27 |
2020-02-26 |
日本ケミファ株式会社 |
オルメサルタンのプロドラッグ製剤
|
|
CA2962122A1
(en)
|
2014-10-08 |
2016-04-14 |
F. Hoffmann-La Roche Ag |
Spirodiamine derivatives as aldosterone synthase inhibitors
|
|
EP3277670A1
(en)
|
2015-04-03 |
2018-02-07 |
Bristol-Myers Squibb Company |
Inhibitors of indoleamine 2,3-dioxygenase for the treatment of cancer
|
|
WO2016161282A1
(en)
|
2015-04-03 |
2016-10-06 |
Incyte Corporation |
Heterocyclic compounds as lsd1 inhibitors
|
|
EP3277277B1
(en)
|
2015-04-03 |
2021-01-06 |
Mutabilis |
Heterocyclic compounds and their use in preventing or treating bacterial infections
|
|
JP7427363B2
(ja)
|
2015-08-12 |
2024-02-05 |
インサイト・ホールディングス・コーポレイション |
Ｌｓｄ１阻害剤の塩
|
|
CN112656772B
(zh)
|
2015-10-15 |
2022-05-20 |
浙江东日药业有限公司 |
利伐沙班药物组合物
|
|
MX2018008052A
(es)
|
2015-12-29 |
2019-03-14 |
Mirati Therapeutics Inc |
Inhibidores de desmetilasa especifica de lisina 1 (lsd1).
|
|
JPWO2017130933A1
(ja)
|
2016-01-25 |
2018-11-29 |
国立大学法人 熊本大学 |
神経変性疾患治療剤
|
|
US10166221B2
(en)
|
2016-04-22 |
2019-01-01 |
Incyte Corporation |
Formulations of an LSD1 inhibitor
|
|
BR112019014759A2
(pt)
|
2017-01-18 |
2020-03-03 |
Vanderbilt University |
Compostos heterocíclicos fundidos como inibidores seletivos de bmp
|
|
UA125592C2
(uk)
|
2017-03-16 |
2022-04-27 |
Джянгсу Хенгруй Медісін Ко., Лтд. |
ПОХІДНА ГЕТЕРОАРИЛ[4,3-c]ПІРИМІДИН-5-АМІНУ, СПОСІБ ЇЇ ОТРИМАННЯ ТА ЇЇ МЕДИЧНІ ЗАСТОСУВАННЯ
|
|
WO2020010197A1
(en)
|
2018-07-05 |
2020-01-09 |
Incyte Corporation |
Fused pyrazine derivatives as a2a / a2b inhibitors
|
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|